[1]
Oleg, C. et al. 2015. INFLUENCE OF A BIOLOGICALLY ACTIVE COMPOUND FROM SUBSTITUTED THIADIAZINES ON TRANSAMINASE ACTIVITY IN MYOCARDIAL HOMOGENATE IN EXPERIMENTAL MYOCARDIAL INFARCTION. International Journal of Pharmacy and Pharmaceutical Sciences. 7, 6 (Jun. 2015), 147–151.